drugset / Trial / NCT00171535

Efficacy and Safety of Valsartan/Amlodipine Combination in Patients With Severe Hypertension

NCT00171535

Phase 3 Completed 130 enrolled Novartis
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will assess the effectiveness and safety of different combination antihypertensive treatments in patients with severe hypertension

Timeline

Start
2004-10
Primary completion
2005-04
Completion
2005-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified
Subject Valsartan Small molecule

Indications